sodium chloride

Generic: sodium chloride

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name sodium chloride
Generic Name sodium chloride
Labeler fresenius kabi usa, llc
Dosage Form INJECTION
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active Ingredients

sodium chloride 9 mg/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-186
Product ID 63323-186_7cda45c6-82d5-4af7-b730-a69bf67fd7ca
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2000-08-10

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323186
Hyphenated Format 63323-186

Supplemental Identifiers

RxCUI
1807632 1807636 1807637 1807638
UPC
0363323186005
UNII
451W47IQ8X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sodium chloride (source: ndc)
Generic Name sodium chloride (source: ndc)
Application Number ANDA088912 (source: label)
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 9 mg/mL
source: ndc
Packaging
  • HOW SUPPLIED: Sodium Chloride Injection, USP, 0.9%, preservative free, is available as follows: Product Code Unit of Sale Each 918602 63323-186-02 Unit of 25 NDC 63323-186-04 2 mL fill, in a 3 mL Single Dose vial 918610 63323-186-10 Unit of 25 NDC 63323-186-01 10 mL Single Dose vial 918620 63323-186-20 Unit of 25 NDC 63323-186-03 20 mL Single Dose vial Preservative Free. Discard unused portion. Use only if solution is clear and seal intact. Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature] www.fresenius-kabi.com/us 45764F Revised: November 2020 Fresenius Kabi Logo
  • PACKAGE LABEL - PRINCIPAL DISPLAY - Sodium Chloride 2 mL Single Dose Vial Label NDC 63323-186-04 918602 Sodium Chloride Injection, USP 0.9% 2 mL Single Dose Vial FOR DRUG DILUENT USE Preservative Free Rx only Discard unused portion. PACKAGE LABEL - PRINCIPAL DISPLAY - Sodium Chloride 2 mL Single Dose Vial Label
  • PACKAGE LABEL - PRINCIPAL DISPLAY - Sodium Chloride 2 mL Single Dose Vial Tray Label NDC 63323-186-02 918602 Sodium Chloride Injection, USP 0.9% FOR DRUG DILUENT USE Rx only 25 x 2 mL Single Dose Vials PACKAGE LABEL - PRINCIPAL DISPLAY - Sodium Chloride 2 mL Single Dose Vial Tray Label
  • PACKAGE LABEL – PRINCIPAL DISPLAY – Sodium Chloride 10 mL Single Dose Vial Label NDC 63323-186-01 918610 Sodium Chloride Injection, USP 0.9% FOR DRUG DILUENT USE Rx only 10 mL Single Dose Vial PACKAGE LABEL – PRINCIPAL DISPLAY – Sodium Chloride 10 mL Single Dose Vial Label
  • PACKAGE LABEL – PRINCIPAL DISPLAY – Sodium Chloride 10 mL Single Dose Vial Tray Label NDC 63323-186-10 918610 Sodium Chloride Injection, USP 0.9% FOR DRUG DILUENT USE Rx only 25 x 10 mL Single Dose Vials PACKAGE LABEL – PRINCIPAL DISPLAY – Sodium Chloride 10 mL Single Dose Vial Tray Label
  • PACKAGE LABEL – PRINCIPAL DISPLAY – Sodium Chloride 20 mL Single Dose Vial Label NDC 63323-186-03 918620 Sodium Chloride Injection, USP 0.9% FOR DRUG DILUENT USE Rx only 20 mL Single Dose Vial PACKAGE LABEL – PRINCIPAL DISPLAY – Sodium Chloride 20 mL Single Dose Vial Label
  • PACKAGE LABEL – PRINCIPAL DISPLAY – Sodium Chloride 20 mL Single Dose Vial Tray Label NDC 63323-186-20 918620 Sodium Chloride Injection, USP 0.9% FOR DRUG DILUENT USE Rx only 25 x 20 mL Single Dose Vials PACKAGE LABEL – PRINCIPAL DISPLAY – Sodium Chloride 20 mL Single Dose Vial Tray Label
source: label

Packages (0)

No package records.

Ingredients (1)

sodium chloride (9 mg/mL)

Linked Drug Pages (2)

Sodium Chloride ndc-match (0.9) Sodium Chloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "7cda45c6-82d5-4af7-b730-a69bf67fd7ca", "openfda": {"upc": ["0363323186005"], "unii": ["451W47IQ8X"], "rxcui": ["1807632", "1807636", "1807637", "1807638"], "spl_set_id": ["f2a98378-9678-4738-9670-fc7a215c0606"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Sodium Chloride", "product_id": "63323-186_7cda45c6-82d5-4af7-b730-a69bf67fd7ca", "dosage_form": "INJECTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "63323-186", "generic_name": "SODIUM CHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sodium Chloride", "active_ingredients": [{"name": "SODIUM CHLORIDE", "strength": "9 mg/mL"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20000810", "listing_expiration_date": "20261231"}